{"cik":1479615,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Silence Therapeutics plc","units":{"USD":[{"start":"2022-01-01","end":"2022-12-31","val":12686000,"accn":"0000950170-25-029129","fy":2024,"fp":"FY","form":"10-K","filed":"2025-02-27","frame":"CY2022"},{"start":"2023-01-01","end":"2023-12-31","val":16274000,"accn":"0000950170-25-029129","fy":2024,"fp":"FY","form":"10-K","filed":"2025-02-27","frame":"CY2023"},{"start":"2024-01-01","end":"2024-12-31","val":16307000,"accn":"0000950170-25-029129","fy":2024,"fp":"FY","form":"10-K","filed":"2025-02-27"},{"start":"2024-01-01","end":"2024-12-31","val":16307000,"accn":"0001193125-26-092591","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-05","frame":"CY2024"},{"start":"2025-01-01","end":"2025-12-31","val":8074000,"accn":"0001193125-26-092591","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-05","frame":"CY2025"}]}}